Search clinical trials for: Amikacin (BAY41-6551)

Total 277 results

Bayer
Nektar Therapeutics

Completed

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Pneumonia

France, Spain, United States
Bayer
Nektar Therapeutics

Completed

Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia

Pneumonia

United States, France
Bayer
Nektar Therapeutics

Completed

Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia (INHALE 1)

Pneumonia, Bacterial

Korea, Republic of, Taiwan, United States, Canada, Philippines, Turkey, Thailand, Australia, Mexico, Colombia, Czechia, Brazil
University Hospital St Luc, Brussels
Université Catholique de Louvain; University of Applied Sciences of Western... and other collaborators

Completed

In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive Ventilation (Synchro-Neb)

Lung Diseases | Asthma | Cystic Fibrosis | COPD | Respiratory Diseases

Belgium
Groupe Hospitalier Pitie-Salpetriere

Completed

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

Pneumonia

France
Raja Isteri Pengiran Anak Saleha Hospital

Terminated

Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation (RIPASA-TWO)

Surgery | Appendicitis

Brunei Darussalam
Cliniques universitaires Saint-Luc- Université...

Unknown

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Cystic Fibrosis | Healthy Subjects

Belgium
Thammasat University

Completed

Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria

Pneumonia, Ventilator-Associated

Thailand
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

Bronchiectasis

China
Cliniques universitaires Saint-Luc- Université...

Unknown

Which Apparatus for Inhaled Pentamidine?

Healthy

Belgium
University Medical Center Groningen

Recruiting

Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™

Tuberculosis

Netherlands
National Heart Institute, Egypt

Completed

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Pneumonia
Bayer

Completed

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A (Leopold I)

Hemophilia A | Blood Coagulation Disorders

Spain, Taiwan, Austria, United States, Germany, Thailand, United Kingdom, Italy, Turkey, Croatia, Serbia, Poland, Israel, Sweden, Indonesia, Argentina, Norway, South Africa, India, Hong Kong, Denmark, Pakistan
Association Pour La Promotion A Tours De La Reanimation...

Unknown

Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation (DARTAGNAN)

Ventilator Associated Pneumonia

France
LEO Pharma
Bayer

Completed

Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne

Acne Vulgaris

United States
Insmed Incorporated

Withdrawn

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Cystic Fibrosis
Cardeas Pharma

Completed

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

Healthy

United States
Insmed Incorporated

Completed

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Healthy Volunteers
Assistance Publique - Hôpitaux de Paris

Completed

Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic (IMPACT)

Ventilator Associated Pneumonia

France
Insmed Incorporated
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Mycobacterium Infections, Nontuberculous

United States, Canada
Pontificia Universidad Catolica de Chile

Completed

Population Pharmacokinetics of Amikacin in Neonates

Neonatal Sepsis, Late-Onset

Chile
Insmed Incorporated

Completed

Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone (CONVERT)

Mycobacterium Infections, Nontuberculous
Centre Hospitalier Universitaire de Nīmes

Completed

Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock (AMINO BESTDOSE)

Shock, Septic

France
Assistance Publique Hopitaux De Marseille

Unknown

Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population (AMIKACINE)

Burn Patients

France
Insmed Incorporated

Completed

Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) Infection

Cystic Fibrosis

France, Poland, United Kingdom, Germany, Spain, Belgium, Bulgaria, Serbia, Denmark, Greece, Netherlands, Hungary, Ireland, Slovakia, Canada, Italy, Austria
Polyphor Ltd.

Completed

DDI Study to Investigate Interaction Between Amikacin and POL7080

Healthy

Germany
Cardeas Pharma

Withdrawn

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

Pneumonia, Bacterial
University Hospital, Basel, Switzerland

Completed

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Febrile Neutropenia (FN)

Switzerland
LivaNova

Completed

Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications (OPTION)

Tachycardia

France, Germany, Portugal, Italy, Canada, United States, Belgium, Netherlands, United Kingdom
Insmed Incorporated

Completed

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Cystic Fibrosis
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session

Cystic Fibrosis

Belgium
University Hospital, Tours

Completed

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia (AMIKINHAL)

Pneumonia, Ventilator-Associated

France
Insmed Incorporated

Completed

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Rambam Health Care Campus

Withdrawn

Amikacin Penetration Into the Cerebrospinal Fluid

Gram Negative Meningitis | Post Traumatic Bacterial Meningitis

Israel
Cardeas Pharma

Completed

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia (IASIS)

Pneumonia, Bacterial

Spain, United States, Greece, Hungary, Turkey, Puerto Rico, France
Khon Kaen University
National Research Council of Thailand

Completed

Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children

Cancer | Neutropenia | Fever
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Conatus Pharmaceuticals Inc.
Idun Pharmaceuticals

Completed

A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

Hepatitis C, Chronic

United States
Therapeutics, Inc.

Completed

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

Psoriasis | Plaque Psoriasis

United States
Ferndale Laboratories, Inc.

Completed

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Bayer

Completed

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis (Phoenix II)

Dermatitis, Atopic

Germany
Merck Sharp & Dohme LLC

Recruiting

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Narcolepsy

United States
University of Alberta
Conatus Pharmaceuticals Inc.

Completed

Caspase Inhibition in Islet Transplantation

Diabetes

Canada
Insmed Incorporated

Completed

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

NTM Lung Infection Due to MAC
Shanghai Zhongshan Hospital
Ruijin Hospital; The First Affiliated Hospital of Guangzhou Medical University

Completed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (PAEAN)

Chronic Obstructive Pulmonary Disease (COPD)

China
Therapeutics, Inc.

Completed

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (305)

Plaque Psoriasis

United States
Therapeutics, Inc.

Completed

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)

Plaque Psoriasis

United States
Conatus Pharmaceuticals Inc.

Completed

PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers

Kidney Diseases | Renal Insufficiency | Renal Impairment | Kidney Disease

United States
Mitsubishi Tanabe Pharma Corporation

Recruiting

A Study of MT-0551 in Patients With Systemic Sclerosis

Systemic Sclerosis

Japan
Alcon Research

Withdrawn

Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis

3

Subscribe